EMBC logo

Embecta (EMBC) Company Overview

Profile

Full Name:

Embecta Corp.

Sector:

Healthcare

Country:

United States

IPO:

March 22, 2022

Indexes:

Not included

Description:

Embecta, formerly part of BD, specializes in diabetes care products, particularly insulin delivery systems and pen needles. The company focuses on improving the lives of people with diabetes by providing innovative, reliable, and easy-to-use solutions for managing their condition effectively.

Key Details

Price

$13.00

Annual Revenue

$1.12 B(+0.21% YoY)

Annual EPS

$1.34(+9.84% YoY)

Annual ROE

-10.61%

Beta

1.17

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Feb 6, 2025

Recent annual earnings:

Nov 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Feb 28, 2025
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 27, 24 BTIG
Buy
Jul 15, 24 Morgan Stanley
Underweight
May 10, 24 Morgan Stanley
Underweight
Nov 22, 23 Morgan Stanley
Underweight
Oct 18, 23 Morgan Stanley
Underweight
Aug 24, 23 Morgan Stanley
Underweight
Jul 18, 23 Morgan Stanley
Underweight
May 15, 23 Morgan Stanley
Underweight
Jan 6, 23 Morgan Stanley
Underweight
Dec 21, 22 Morgan Stanley
Equal-Weight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Embecta?
  • Does Embecta pay dividends?
  • What sector is Embecta in?
  • What industry is Embecta in?
  • What country is Embecta based in?
  • When did Embecta go public?
  • Is Embecta in the S&P 500?
  • Is Embecta in the NASDAQ 100?
  • Is Embecta in the Dow Jones?
  • When was Embecta's last earnings report?
  • When does Embecta report earnings?
  • Should I buy Embecta stock now?

What is the ticker symbol for Embecta?

The ticker symbol for Embecta is NASDAQ:EMBC

Does Embecta pay dividends?

Yes, Embecta pays dividends. The last payment was $0.15, with an ex-dividend date on February 28, 2025

What sector is Embecta in?

Embecta is in the Healthcare sector

What industry is Embecta in?

Embecta is in the Medical Instruments & Supplies industry

What country is Embecta based in?

Embecta is headquartered in United States

When did Embecta go public?

Embecta's initial public offering (IPO) was on March 22, 2022

Is Embecta in the S&P 500?

No, Embecta is not included in the S&P 500 index

Is Embecta in the NASDAQ 100?

No, Embecta is not included in the NASDAQ 100 index

Is Embecta in the Dow Jones?

No, Embecta is not included in the Dow Jones index

When was Embecta's last earnings report?

Embecta's most recent earnings report was on Feb 6, 2025

When does Embecta report earnings?

The next expected earnings date for Embecta is May 9, 2025

Should I buy Embecta stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions